Presentation and Spectrum of Male Breast Cancer in a Rural Cancer Center in a Subunit of Tata Memorial Center, India
Autor: | Sachin Khandelwal, Alok Goel, Tapas Dora, Rakesh Sharma, Priyanka Goel, Sankalp Sancheti, Nirmaljot Kaur, Rakesh Kapoor, Debashish Chaudhary |
---|---|
Rok vydání: | 2021 |
Předmět: |
medicine.medical_specialty
business.industry Incidence (epidemiology) Cancer Retrospective cohort study medicine.disease Metastasis 03 medical and health sciences 0302 clinical medicine Breast cancer Oncology 030220 oncology & carcinogenesis Internal medicine Male breast cancer medicine Population study Original Article 030211 gastroenterology & hepatology Surgery Family history skin and connective tissue diseases business |
Zdroj: | Indian J Surg Oncol |
ISSN: | 0976-6952 0975-7651 |
DOI: | 10.1007/s13193-021-01306-8 |
Popis: | This is a retrospective study of the incidence and clinical profile of male breast cancer (MBC) presenting to a rural cancer center in Punjab, India. All MBC cases registered over a period of 4.5 years from January 2015 to July 2019 were included. The study included 34 MBC patients accounting for 1.9% of all breast cancer cases with median age of 62.5 years. All patients were from Punjab except one, with majority from district Sangrur. Family history was present in 7 (20.6%) patients. Mean BMI (n = 23) was 24.8. The median duration of symptoms was 6 months (range 1–60 months). Main complaint was lump in 58.8% of patients followed by lump with ulceration (41.2%). All cases were mostly unilateral, left in 21 (61.8%) and right in 13 (38.2%), and one had bilateral breast cancer. Most tumors were centrally located (70.6%). Infiltrating ductal carcinoma and grade 3 were the commonest histology. ER positivity was high seen in 76.5% cases. In our study, 16 (47.1%) patients presented with distant metastasis at the time of diagnosis, and 10 (39.1%) were locally advance. Bone (41%) followed by lung (17%) were the most common sites of metastasis. Thirteen patients were treated radically, nine were treated with palliative intent, and twelve patients defaulted. Median follow-up period was 16.5 months. MBC constituted 1.9% of all breast cancers registered at our institute, which is higher than worldwide average. Our study population had a longer time to presentation, and majority were metastatic. |
Databáze: | OpenAIRE |
Externí odkaz: |